{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T07:25:06Z","timestamp":1777965906273,"version":"3.51.4"},"reference-count":99,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","internationaljournalofcardiology.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.ijcard.2018.08.080","type":"journal-article","created":{"date-parts":[[2018,8,27]],"date-time":"2018-08-27T19:06:27Z","timestamp":1535396787000},"page":"53-62","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"special_numbering":"S","title":["Pulmonary hypertension associated with left heart disease: Updated Recommendations of the Cologne Consensus Conference 2018"],"prefix":"10.1016","volume":"272","author":[{"given":"Stephan","family":"Rosenkranz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene M.","family":"Lang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R\u00fcdiger","family":"Blindt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana","family":"Bonderman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonhard","family":"Bruch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerhard P.","family":"Diller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralf","family":"Felgendreher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Gerges","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Hohenforst-Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Holt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrid","family":"Kindermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tilmann","family":"Kramer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang M.","family":"K\u00fcbler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veselin","family":"Mitrovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Riedel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Rieth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Schmeisser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rolf","family":"Wachter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joachim","family":"Weil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian F.","family":"Opitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2018.08.080_bb0005","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S2213-2600(15)00543-3","article-title":"A global view of pulmonary hypertension","volume":"4","author":"Hoeper","year":"2016","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.ijcard.2018.08.080_bb0010","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1093\/eurheartj\/ehv512","article-title":"Left ventricular heart failure and pulmonary hypertension","volume":"37","author":"Rosenkranz","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2018.08.080_bb0015","doi-asserted-by":"crossref","first-page":"D100","DOI":"10.1016\/j.jacc.2013.10.033","article-title":"Pulmonary hypertension due to left heart disease","volume":"62","author":"Vachiery","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2018.08.080_bb0020","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.healun.2012.06.002","article-title":"World Health Organization Pulmonary Hypertension Group 2: pulmonary hypertension due to left heart disease in the adult\u2014a summary statement from the Pulmonary Hypertension Council of the International Society for Heart and Lung Transplantation","volume":"31","author":"Fang","year":"2012","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.ijcard.2018.08.080_bb0025","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1161\/CIRCHEARTFAILURE.110.958801","article-title":"Clinical characteristics of pulmonary hypertension in patients with heart failure and preserved ejection fraction","volume":"4","author":"Thenappan","year":"2011","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.ijcard.2018.08.080_bb0030","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1378\/chest.08-2008","article-title":"Association of the metabolic syndrome with pulmonary venous hypertension","volume":"136","author":"Robbins","year":"2009","journal-title":"Chest"},{"key":"10.1016\/j.ijcard.2018.08.080_bb0035","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.jacc.2016.05.047","article-title":"Pre-capillary, combined, and post-capillary pulmonary hypertension: a pathophysiological continuum","volume":"68","author":"Opitz","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"issue":"37","key":"10.1016\/j.ijcard.2018.08.080_bb0040","first-page":"67","volume":"2016","author":"Gali\u00e8","year":"2015","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2018.08.080_bb0045","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1161\/01.CIR.102.14.1718","article-title":"Secondary pulmonary hypertension in chronic heart failure: the role of the endothelium in pathophysiology and management","volume":"102","author":"Moraes","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2018.08.080_bb0050","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1093\/eurheartj\/ehp297","article-title":"Guidelines on diagnosis and treatment of pulmonary hypertension: the Task Force on Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology and of the European Respiratory Society","volume":"30","author":"Gali\u00e8","year":"2009","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2018.08.080_bb0055","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jchf.2013.05.001","article-title":"Clinical features, hemodynamics, and outcomes of pulmonary hypertension due to chronic heart failure with reduced ejection fraction","volume":"1","author":"Miller","year":"2013","journal-title":"JACC Heart Fail."},{"key":"10.1016\/j.ijcard.2018.08.080_bb0060","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1378\/chest.12-1653","article-title":"Diastolic pulmonary vascular pressure gradient. A predictor of prognosis in out-of-proportion pulmonary hypertension","volume":"143","author":"Gerges","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.ijcard.2018.08.080_bb0065","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1183\/09031936.00074312","article-title":"The transpulmonary pressure gradient for the diagnosis of pulmonary vascular disease","volume":"41","author":"Naeije","year":"2013","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ijcard.2018.08.080_bb0070","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1016\/j.jacc.2016.09.942","article-title":"Clinical and biological insights into combined post- and pre-capillary pulmonary hypertension","volume":"68","author":"Assad","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2018.08.080_bb0075","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1016\/j.jacc.2017.01.051","article-title":"Pulmonary hypertension in heart failure: pathophysiology, pathobiology, and emerging clinical perspectives","volume":"69","author":"Guazzi","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2018.08.080_bb0080","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1183\/13993003.00432-2016","article-title":"How to define pulmonary hypertension due to left heart disease","volume":"48","author":"Gerges","year":"2016","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ijcard.2018.08.080_bb0085","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/ejhf.860","article-title":"Pulmonary hypertension due to left-heart disease: analysis of survival according to the hemodynamic classification of the 2015 ESC\/ERS guidelines and new insights for future changes","volume":"20","author":"Palazzini","year":"2018","journal-title":"Eur. J. Heart Fail."},{"issue":"4","key":"10.1016\/j.ijcard.2018.08.080_bb0090","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02427-2017","article-title":"Haemodynamics to predict outcome in pulmonary hypertension due to left heart disease: a meta-analysis","volume":"51","author":"Caravita","year":"2018","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ijcard.2018.08.080_bb0095","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1001\/jamacardio.2018.0128","article-title":"Association between hemodynamic markers of pulmonary hypertension and outcomes in heart failure with preserved ejection fraction","volume":"3","author":"Vanderpool","year":"2018","journal-title":"JAMA Cardiol."},{"issue":"18","key":"10.1016\/j.ijcard.2018.08.080_bb0100","first-page":"891","volume":"2016","author":"Ponikowski","year":"2016","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.ijcard.2018.08.080_bb0105","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0735-1097(00)01102-5","article-title":"Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure","volume":"37","author":"Ghio","year":"2001","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2018.08.080_bb0110","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jchf.2014.07.010","article-title":"The diastolic pulmonary gradient does not predict survival in patients with pulmonary hypertension due to left heart disease","volume":"3","author":"Tampakakis","year":"2015","journal-title":"JACC Heart Fail."},{"key":"10.1016\/j.ijcard.2018.08.080_bb0115","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.jacc.2008.11.051","article-title":"Pulmonary hypertension in heart failure with preserved ejection fraction. A community-based study","volume":"53","author":"Lam","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2018.08.080_bb0120","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.amjcard.2010.02.039","article-title":"Prevalence and risk factors of pulmonary hypertension in patients with elevated pulmonary venous pressure and preserved ejection fraction","volume":"106","author":"Leung","year":"2010","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2018.08.080_bb0125","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1161\/CIRCHEARTFAILURE.113.000887","article-title":"Cardiac structure and function in heart failure with preserved ejection fraction: Baseline findings from the echocardiographic study of the treatment of preserved cardiac function heart failure with an aldosterone antagonist trial (TOPCAT)","volume":"7","author":"Shah","year":"2014","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.ijcard.2018.08.080_bb0130","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jacc.2011.06.076","article-title":"Pulmonary pressures and death in heart failure: a community study","volume":"59","author":"Bursi","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2018.08.080_bb0135","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1093\/eurheartj\/ehu193","article-title":"Right heart dysfunction in heart failure with preserved ejection fraction","volume":"35","author":"Melenovsky","year":"2014","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2018.08.080_bb0140","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1161\/CIRCULATIONAHA.113.008461","article-title":"Right ventricular function in heart failure with preserved ejection fraction: a community-based study","volume":"130","author":"Mohammed","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2018.08.080_bb0145","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1378\/chest.13-1510","article-title":"Prognostic relevance of pulmonary arterial compliance in patients with chronic heart failure","volume":"145","author":"Pellegrini","year":"2014","journal-title":"Chest"},{"key":"10.1016\/j.ijcard.2018.08.080_bb0150","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/ejhf.192","article-title":"Pulmonary arterial capacitance in patients with with heart failure and reactive pulmonary hypertension","volume":"17","author":"Dragu","year":"2015","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2018.08.080_bb0155","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.jchf.2015.01.013","article-title":"Pulmonary arterial capacitance is an important predictor of mortality in heart failure with a preserved ejection fraction","volume":"3","author":"Al-Naamani","year":"2015","journal-title":"JACC Heart Fail."},{"key":"10.1016\/j.ijcard.2018.08.080_bb0160","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.115.003011","article-title":"Pulmonary vascular distensibility predicts pulmonary hypertension severity, exercise capacity, and survival in heart failure","volume":"9","author":"Malhotra","year":"2016","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.ijcard.2018.08.080_bb0165","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1164\/rccm.201503-0529OC","article-title":"Pulmonary hypertension in heart failure. Epidemiology, right ventricular function, and survival","volume":"192","author":"Gerges","year":"2015","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ijcard.2018.08.080_bb0170","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.jacc.2015.07.011","article-title":"Diastolic pressure gradient predicts outcome in patients with heart failure and preserved ejection fraction","volume":"66","author":"Zotter-Tufaro","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2018.08.080_bb0175","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jchf.2014.09.002","article-title":"Characterization of pulmonary hypertension in heart failure using the diastolic pressure gradient: limitations of a solitary measurement","volume":"3","author":"Chatterjee","year":"2015","journal-title":"JACC Heart Fail."},{"key":"10.1016\/j.ijcard.2018.08.080_bb0180","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.healun.2017.02.022","article-title":"Hemodynamic phenotyping based on exercise catheterization predicts outcome in patients with heart failure and reduced ejection fraction","volume":"36","author":"Rieth","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.ijcard.2018.08.080_bb0185","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.jtcvs.2016.02.038","article-title":"The impact of concomitant pulmonary hypertension on early and late outcomes following surgery for mitral stenosis","volume":"152","author":"Yang","year":"2016","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.ijcard.2018.08.080_bb0190","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1093\/eurjhf\/hfq014","article-title":"Prognostic implications of functional mitral regurgitation according to the severity of the underlying chronic heart failure: a long-term outcome study","volume":"12","author":"Bursi","year":"2010","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2018.08.080_bb0195","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1161\/CIRCIMAGING.112.000162","article-title":"Prognostic significance of exercise-induced right ventricular dysfunction in asymptomatic degenerative mitral regurgitation","volume":"6","author":"Kusunose","year":"2013","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"10.1016\/j.ijcard.2018.08.080_bb0200","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.amjcard.2015.02.028","article-title":"Clinical significance of exercise pulmonary hypertension in secondary mitral regurgitation","volume":"115","author":"Lancellotti","year":"2015","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2018.08.080_bb0205","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1136\/heartjnl-2011-300705","article-title":"Acute haemodynamic changes after percutaneous mitral valve repair: relation to mid-term outcomes","volume":"98","author":"Gaemperli","year":"2012","journal-title":"Heart"},{"key":"10.1016\/j.ijcard.2018.08.080_bb0210","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/ejhf.864","article-title":"Implication of pulmonary hypertension in patients undergoing MitraClip therapy: results from the German transcatheter mitral valve interventions (TRAMI) registry","volume":"20","author":"Tigges","year":"2018","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2018.08.080_bb0215","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/S0002-9149(99)00643-8","article-title":"Pulmonary artery hypertension in adult patients with symptomatic valvular aortic stenosis","volume":"85","author":"Faggiano","year":"2000","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2018.08.080_bb0220","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/j.jtcvs.2011.02.028","article-title":"Impact of pulmonary hypertension on outcomes after aortic valve replacement for aortic valve stenosis","volume":"141","author":"Melby","year":"2011","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.ijcard.2018.08.080_bb0225","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s00392-011-0367-3","article-title":"Prognostic value of mild-to-moderate pulmonary hypertension in patients with severe aortic valve stenosis undergoing aortic valve replacement","volume":"101","author":"Zuern","year":"2012","journal-title":"Clin. Res. Cardiol."},{"key":"10.1016\/j.ijcard.2018.08.080_bb0230","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/j.amjcard.2013.07.025","article-title":"Effect of pulmonary hypertension on outcomes in patients with severe aortic stenosis following surgical aortic valve replacement","volume":"112","author":"Zlotnick","year":"2013","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2018.08.080_bb0235","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1093\/eurheartj\/ehx391","article-title":"ESC Scientific Document Group. 2017 ESC\/EACTS Guidelines for the management of valvular heart disease","volume":"38","author":"Baumgartner","year":"2017","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2018.08.080_bb0240","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S1010-7940(99)00106-2","article-title":"Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19030 patients","volume":"15","author":"Roques","year":"1999","journal-title":"Eur. J. Cardiothorac. Surg."},{"key":"10.1016\/j.ijcard.2018.08.080_bb0245","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1161\/CIRCINTERVENTIONS.113.000482","article-title":"Prognostic implications of pulmonary hypertension in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation: study from the FRANCE 2 registry","volume":"7","author":"Lu\u00e7on","year":"2014","journal-title":"Circ. Cardiovasc. Interv."},{"key":"10.1016\/j.ijcard.2018.08.080_bb0250","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.4244\/EIJV9I9A177","article-title":"Decrease of pulmonary hypertension impacts on prognosis after transcatheter aortic valve replacement","volume":"9","author":"Sinning","year":"2014","journal-title":"EuroIntervention"},{"key":"10.1016\/j.ijcard.2018.08.080_bb0255","volume":"8","author":"O'Sullivan","year":"2015","journal-title":"Circ. Cardiovasc. Interv."},{"key":"10.1016\/j.ijcard.2018.08.080_bb0260","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1136\/heartjnl-2017-311978","article-title":"Outcomes of persistent pulmonary hypertension following transcatheter aortic valve replacement","volume":"104","author":"Masri","year":"2018","journal-title":"Heart"},{"key":"10.1016\/j.ijcard.2018.08.080_bb0265","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1093\/europace\/eus153","article-title":"Atrial Fibrillation Ablation Pilot Study Investigators. ESC-EURObservational Research Programme: the Atrial Fibrillation Ablation Pilot Study, conducted by the European Heart Rhythm Association","volume":"14","author":"Arbelo","year":"2012","journal-title":"Europace"},{"key":"10.1016\/j.ijcard.2018.08.080_bb0270","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1055\/s-0031-1292858","article-title":"Rechtherzkatheter-Untersuchung bei pulmonaler Hypertonie","volume":"136","author":"Rosenkranz","year":"2011","journal-title":"Dtsch. Med. Wochenschr."},{"key":"10.1016\/j.ijcard.2018.08.080_bb0275","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.chest.2016.08.1439","article-title":"Clinical relevance of fluid challenge in patients evaluated for pulmonary hypertension","volume":"151","author":"D'Alto","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.ijcard.2018.08.080_bb0280","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1161\/CIRCHEARTFAILURE.113.000468","article-title":"High prevalence of occult pulmonary venous hypertension revealed by fluid challenge in pulmonary hypertension","volume":"7","author":"Robbins","year":"2014","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.ijcard.2018.08.080_bb0285","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1056\/NEJMoa1413687","article-title":"Initial use of Ambrisentan plus Tadalafil in pulmonary arterial hypertension","volume":"379","author":"Gali\u00e8","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2018.08.080_bb0290","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1161\/CIRCULATIONAHA.114.010637","article-title":"Phenomapping for novel classification of heart failure with preserved ejection fraction","volume":"131","author":"Shah","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2018.08.080_bb0295","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jacc.2016.04.052","article-title":"Functional status, pulmonary artery pressure, and clinical outcomes in heart failure with preserved ejection fraction","volume":"68","author":"Dalos","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2018.08.080_bb0300","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1056\/NEJMoa1510774","article-title":"Isosorbide mononitrate in heart failure with preserved ejection fraction","volume":"373","author":"Redfield","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2018.08.080_bb0305","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.athoracsur.2008.05.016","article-title":"Right heart dysfunction after left ventricular assist device implantation: a comparison of the pulsatile HeartMate I and axial-flow HeartMate II devices","volume":"86","author":"Patel","year":"2008","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.ijcard.2018.08.080_bb0310","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.healun.2009.05.030","article-title":"Reversal of secondary pulmonary hypertension by axial and pulsatile mechanical circulatory support","volume":"29","author":"Torre-Amione","year":"2010","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.ijcard.2018.08.080_bb0315","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.jtcvs.2006.08.104","article-title":"Left ventricular assist devices decrease fixed pulmonary hypertension in cardiac transplant candidates","volume":"133","author":"Zimpfer","year":"2007","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.ijcard.2018.08.080_bb0320","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.cardfail.2016.06.421","article-title":"Left ventricular assist devices or inotropes for decreasing pulmonary vascular resistance in patients with pulmonary hypertension listed for heart transplantation","volume":"23","author":"Al Kindi","year":"2017","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.ijcard.2018.08.080_bb0325","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.117.003882","article-title":"Decoupling between diastolic pulmonary artery pressure and pulmonary capillary wedge pressure as a prognostic factor after continuous flow ventricular assist device implantation","volume":"10","author":"Imamura","year":"2017","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.ijcard.2018.08.080_bb0330","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/S0140-6736(16)00704-2","article-title":"REDUCE LAP-HF study investigators. A transcatheter intracardiac shunt device for heart failure with preserved ejection fraction (REDUCE LAP-HF): a multicentre, open-label, single-arm, phase 1 trial","volume":"387","author":"Hasenfu\u00df","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2018.08.080_bb0335","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1161\/CIRCULATIONAHA.113.001458","article-title":"Riociguat for patients with pulmonary hypertension caused by systolic left ventricular dysfunction: a phase IIb double-blind, randomized, placebo-controlled, dose-ranging hemodynamic study","volume":"128","author":"Bonderman","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2018.08.080_bb0340","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1016\/j.jacc.2007.07.078","article-title":"Long-term use of sildenafil in the therapeutic management of heart failure","volume":"50","author":"Guazzi","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2018.08.080_bb0345","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S0195-668X(02)00700-5","article-title":"The EuroHeart Failure Survey programme \u2013 a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment","volume":"24","author":"Komajda","year":"2003","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2018.08.080_bb0350","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1056\/NEJMoa010641","article-title":"Prognostic importance of elevated jugular venous pressure and a third heart sound in patients with heart failure","volume":"345","author":"Drazner","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2018.08.080_bb0355","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.ahj.2007.01.041","article-title":"Repeated hospitalizations predict mortality in the community population with heart failure","volume":"154","author":"Setoguchi","year":"2007","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ijcard.2018.08.080_bb0360","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/eurheartj\/ehs444","article-title":"Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the EVEREST trial","volume":"34","author":"Ambrosy","year":"2013","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2018.08.080_bb0365","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1161\/CIRCULATIONAHA.108.783910","article-title":"Transition from chronic compensated to acute decompensated heart failure: pathophysiological insights obtained from continuous monitoring of intracardiac pressures","volume":"118","author":"Zile","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2018.08.080_bb0370","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.ahj.2009.02.022","article-title":"Effect of pulmonary hypertension on clinical outcomes in advanced heart failure: analysis of the Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE) database","volume":"157","author":"Khush","year":"2009","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ijcard.2018.08.080_bb0375","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/eurjhf\/hfq045","article-title":"Assessing and grading congestion in acute heart failure: a scientific statement from the Acute Heart Failure Committee of the Heart Failure Association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medicine","volume":"12","author":"Gheorghiade","year":"2010","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2018.08.080_bb0380","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1093\/eurheartj\/ehu065","article-title":"Diuretic response in acute heart failure: clinical characteristics and prognostic significance","volume":"35","author":"Valente","year":"2014","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2018.08.080_bb0385","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.echo.2010.05.010","volume":"23","author":"Rudski","year":"2010","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"10.1016\/j.ijcard.2018.08.080_bb0390","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jcmg.2012.08.012","article-title":"IVC diameter in patients with chronic heart failure: relationships and prognostic significance","volume":"6","author":"Pellicori","year":"2013","journal-title":"JACC Cardiovasc. Imaging"},{"key":"10.1016\/j.ijcard.2018.08.080_bb0395","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1097\/TA.0000000000000152","article-title":"Prospective evaluation of intravascular volume status in critically ill patients: does inferior vena cava collapsibility correlate with central venous pressure?","volume":"76","author":"Stawicki","year":"2014","journal-title":"J. Trauma Acute Care Surg."},{"key":"10.1016\/j.ijcard.2018.08.080_bb0400","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ijcard.2009.08.001","article-title":"BNP at discharge in acute heart failure patients: is it all about volemia? A study using impedance cardiography to assess fluid and hemodynamic status","volume":"145","author":"Pimenta","year":"2010","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2018.08.080_bb0405","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.ejheart.2008.07.014","article-title":"State of the art: using natriuretic peptide levels in clinical practice","volume":"10","author":"Maisel","year":"2008","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2018.08.080_bb0410","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1002\/ejhf.417","article-title":"Lung congestion in chronic heart failure: haemodynamic, clinical, and prognostic implications","volume":"17","author":"Melenovsky","year":"2015","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2018.08.080_bb0415","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jacc.2013.05.027","article-title":"Timing of hemoconcentration during treatment of acute decompensated heart failure and subsequent survival: importance of sustained decongestion","volume":"62","author":"Testani","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2018.08.080_bb0420","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.cardfail.2011.08.004","article-title":"Clinical correlates of hemoconcentration during hospitalization for acute decompensated heart failure","volume":"17","author":"Davila","year":"2011","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.ijcard.2018.08.080_bb0425","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1159\/000360604","article-title":"Association of hyponatremia to diuretic response and incidence of increased serum creatinine levels in hospitalized patients with acute decompensated heart failure","volume":"128","author":"Ng","year":"2014","journal-title":"Cardiology"},{"key":"10.1016\/j.ijcard.2018.08.080_bb0430","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.jacc.2014.12.010","article-title":"Hyponatremia in acute decompensated heart failure: depletion versus dilution","volume":"65","author":"Verbrugge","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2018.08.080_bb0435","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.cardfail.2010.08.002","article-title":"CHAMPION trial rationale and design: the long-term safety and clinical efficacy of a wireless pulmonary artery pressure monitoring system","volume":"17","author":"Adamson","year":"2011","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.ijcard.2018.08.080_bb0440","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0140-6736(15)00723-0","article-title":"Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete follow-up results from the CHAMPION randomised trial","volume":"387","author":"Abraham","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2018.08.080_bb0445","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1161\/CIRCULATIONAHA.110.983866","article-title":"Pulmonary hypertension in heart failure with preserved ejection fraction: a target of phosphodiesterase-5 inhibition in a 1-year study","volume":"124","author":"Guazzi","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2018.08.080_bb0450","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.hfc.2012.04.009","article-title":"Pulmonary hypertension associated with left-sided heart disease","volume":"8","author":"Barnett","year":"2012","journal-title":"Heart Fail. Clin."},{"key":"10.1016\/j.ijcard.2018.08.080_bb0455","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jchf.2017.02.021","article-title":"Long-term effect of endothelin receptor antagonism with bosentan on the morbidity and mortality of patients with severe chronic heart failure: primary results of the ENABLE trials","volume":"5","author":"Packer","year":"2017","journal-title":"JACC Heart Fail."},{"issue":"2","key":"10.1016\/j.ijcard.2018.08.080_bb0460","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01886-2017","article-title":"Macitentan in pulmonary hypertension due to left ventricular dysfunction","volume":"51","author":"Vachi\u00e9ry","year":"2018","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ijcard.2018.08.080_bb0465","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1093\/eurheartj\/ehx700","article-title":"Sildenafil for improving outcomes in patients with corrected valvular heart disease and persistent pulmonary hypertension: a multicenter, double-blind, randomized clinical trial","volume":"39","author":"Bermejo","year":"2018","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2018.08.080_bb0470","first-page":"2869","article-title":"Pulmonary hypertension in heart failure with preserved ejection fraction: a plea for proper phenotyping and further research","volume":"38","author":"Hoeper","year":"2017","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2018.08.080_bb0475","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1093\/eurheartj\/ehx184","article-title":"Is it time to recognize a new phenotype? Heart failure with preserved ejection fraction with pulmonary vascular disease","volume":"38","author":"Borlaug","year":"2017","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2018.08.080_bb0480","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1001\/jama.2013.2024","article-title":"Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial","volume":"309","author":"Redfield","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2018.08.080_bb0485","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1093\/eurheartj\/ehv336","article-title":"Effects of sildenafil on invasive haemodynamics and exercise capacity in heart failure patients with preserved ejection fraction and pulmonary hypertension: a randomized controlled trial","volume":"36","author":"Hoendermis","year":"2015","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2018.08.080_bb0490","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1001\/jama.2015.15734","article-title":"Effect of Vericiguat, a soluble guanylate cyclase stimulator, on natriuretic peptide levels in patients with worsening chronic heart failure and reduced ejection fraction: the Socrates-Reduced randomized trial","volume":"314","author":"Gheorghiade","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2018.08.080_bb0495","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1093\/eurheartj\/ehw593","article-title":"Vericiguat in patients with worsening chronic heart failure and preserved ejection fraction: results from the SOluble guanylate cyclase stimulatoR in heArT failurE patientS with PRESERVED EF (SOCRATES-PRESERVED) study","volume":"38","author":"Pieske","year":"2017","journal-title":"Eur. Heart J."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527318343523?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527318343523?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,29]],"date-time":"2018-12-29T20:47:51Z","timestamp":1546116471000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527318343523"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":99,"alternative-id":["S0167527318343523"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2018.08.080","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pulmonary hypertension associated with left heart disease: Updated Recommendations of the Cologne Consensus Conference 2018","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2018.08.080","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}